Stay updated on FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Sign up to get notified when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.

Latest updates to the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedMinor revision update: Revision changed from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1. No user-facing content changes detected.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, with no substantive changes to the study details visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded detailed Locations sections for multiple sites (California, Illinois, Massachusetts, New York, Rio de Janeiro, São Paulo, Lazio, Liguria, Lombardy, Moscow Oblast, Barcelona). Removed HHS Vulnerability Disclosure link and updated page revision to v3.3.3.SummaryDifference1.0%

- Check92 days agoChange DetectedPublications section wording updated to state that publications are automatically filled from PubMed. The page revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check99 days agoChange DetectedThe funding-status notice was removed, but the core trial details (overview, eligibility, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.